Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Lupeng Pharmaceutical Company Ltd.

Clinical trials sponsored by Guangzhou Lupeng Pharmaceutical Company Ltd., explained in plain language.

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for tough lymphoma: oral drug targets resistant cancer

Disease control Ongoing

This study tests an experimental oral drug called rocbrutinib in 62 adults with mantle cell lymphoma whose cancer has come back or stopped responding to a previous targeted therapy. The goal is to see if the drug can shrink tumors. Participants take the drug by mouth, and the stu…

Phase: PHASE2 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control

Last updated May 17, 2026 05:36 UTC